Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Maggiolo

Showing results (41-50 of 161) with videos related to

Pageof 17
Sort By:
HIV Clinical Trials|October 31, 2002
Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patientsFranco Maggiolo, Diego Ripamonti, Claudio Arici, et al.
HIV Clinical Trials|October 25, 2007
Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patientsFranco Maggiolo, Monica Airoldi, Hendrik Daniël Kleinloog, et al.
Blood|May 31, 2002
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis CEliseo Minola, Daniele Prati, Fredy Suter, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|June 1, 2007
Prediction of Virologic Outcome of Salvage Antiretroviral Treatment by Different Systems for Interpreting Genotypic HIV Drug ResistanceFranco Maggiolo, Monica Airoldi, Annapaola Callegaro, et al.
BMC Infectious Diseases|March 18, 2017
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patientsFranco Maggiolo, Roberto Gulminetti, Layla Pagnucco, et al.
HIV Clinical Trials|April 17, 2007
Resistance costs and future drug options of antiretroviral therapies: analysis of the role of NRTIs, NNRTIs, and PIs in a large clinical cohortFranco Maggiolo, Diego Ripamonti, Monica Airoldi, et al.
AIDS Care|August 2, 2011
Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimenRaffaella Rosso, Antonio Di Biagio, Franco Maggiolo, et al.
Antiviral Therapy|May 14, 2003
Salvage therapy with abacavir in HIV-1-infected patients with previously documented M184V mutation: a possibility of NRTI recyclingFranco Maggiolo, Annapaola Callegaro, Claudio Arici, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2007
Reasons for discontinuation of nevirapine-containing HAART: results from an unselected population of a large clinical cohortFranco Maggiolo, Claudio Arici, Monica Airoldi, et al.
Journal of the International AIDS Society|November 15, 2014
Long-term effect of a four-drugs induction regimen for patients with high baseline viral loadFranco Maggiolo, Giulia Masini, Noemi Astuti, et al.
Pageof 17

Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
HIV Clinical Trials|October 31, 2002
Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patientsFranco Maggiolo, Diego Ripamonti, Claudio Arici, et al.
HIV Clinical Trials|October 25, 2007
Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patientsFranco Maggiolo, Monica Airoldi, Hendrik Daniël Kleinloog, et al.
Blood|May 31, 2002
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis CEliseo Minola, Daniele Prati, Fredy Suter, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|June 1, 2007
Prediction of Virologic Outcome of Salvage Antiretroviral Treatment by Different Systems for Interpreting Genotypic HIV Drug ResistanceFranco Maggiolo, Monica Airoldi, Annapaola Callegaro, et al.
BMC Infectious Diseases|March 18, 2017
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patientsFranco Maggiolo, Roberto Gulminetti, Layla Pagnucco, et al.
HIV Clinical Trials|April 17, 2007
Resistance costs and future drug options of antiretroviral therapies: analysis of the role of NRTIs, NNRTIs, and PIs in a large clinical cohortFranco Maggiolo, Diego Ripamonti, Monica Airoldi, et al.
AIDS Care|August 2, 2011
Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimenRaffaella Rosso, Antonio Di Biagio, Franco Maggiolo, et al.
Antiviral Therapy|May 14, 2003
Salvage therapy with abacavir in HIV-1-infected patients with previously documented M184V mutation: a possibility of NRTI recyclingFranco Maggiolo, Annapaola Callegaro, Claudio Arici, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2007
Reasons for discontinuation of nevirapine-containing HAART: results from an unselected population of a large clinical cohortFranco Maggiolo, Claudio Arici, Monica Airoldi, et al.
Journal of the International AIDS Society|November 15, 2014
Long-term effect of a four-drugs induction regimen for patients with high baseline viral loadFranco Maggiolo, Giulia Masini, Noemi Astuti, et al.
Pageof 17